ACT T-cells
adjuvant drug
administration of targeted particles
adoptively-transferred T-cells
cancer immunotherapy
cell
cell-bound particles
cell division
elimination of large tumor burdens
expansion of the cell population in vivo
internalizing targeting ligands
nanoparticle carrier
nanoparticle drug carriers
nanoparticles
peptide-MHC-functionalized nanoparticles
peptide-MHC ligands
pharmacyte approach
“re-arming” of T-cells with supporting drugs
stimulation
supporting adjuvant drugs
supporting drugs
targeted particles
T-cell receptors
T-cells
transferred lymphocytes
treating graft rejection or autoimmunity
